“Being brave, being seen, and having your voice heard”: Perspectives of self‐advocates and families toward accessible and impactful research of Alzheimer's disease in down syndrome
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Sarah Walter und 20 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Biomedical Research, Patient Advocacy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, US National Institute on Aging, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Over 220,000 people live with Down syndrome (DS) in the United States, with an average life expectancy of 63.5 years of age. The high risk for Alzheimer's disease (AD) in DS means studies must be accessible and inclusive. We share our experience of building a collaborative group of self‐advocates and care partners to provide meaningful feedback on research. METHODS Our research partnership group is supported by the Alzheimer's Clinical Trials Consortium—Down Syndrome (ACTC‐DS) and Alzheimer's Biomarker Consortium Down Syndrome (ABC‐DS). We synthesize feedback into themes and recommendations for researchers. RESULTS Feedback themes are broad, extending from the strong motivation to engage in research to the need to balance study burden and risk. Recommendations for researchers include providing support and connection to resources, sharing individual and study‐level results, flexibility, and respectful communication. DISCUSSION Our collaborative approach will lead to more relevant and accessible research studies. Highlights Inclusive and accessible research is needed for Down syndrome and Alzheimer's disease. We built a collaborative group of self‐advocates and care partners to provide feedback. Feedback includes a strong motivation to learn about brain health and engage in research. Respectful communication includes representative images and tailored materials. Recommendations include the choice to learn individual results, flexibility, and support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
- Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Pathology & Laboratory Medicine, and Neurology, School of Medicine, University of California, Irvine, Irvine, California, USA.
- Alzheimer's Disease Research Center, University Of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Alzheimer's Therapeutic Research Institute, University of Southern California, Alzheimer's Clinical Trials Consortium Down Syndrome and Alzheimer's Biomarker Consortium Down Syndrome Research Partnership Group, San Dieg…
ORCID-Profile: Sarah Walter
Förderung
- NIA NIH HHS
- US National Institute on Aging
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute on Aging
Zitieren
APA
Walter, S., Ptomey, L., Head, E., Cohen, A., Briones, J. M., Shaw, H., Carter, B., Kishner, J., Pestolesi, W., Sciullo, A., Olmstead, K. K., Carter, A., Kishner, S., Tucker, A. K., Pestolesi, L., Briones, M., Sciullo, D., Sciullo, K., Shaw, P., …, & Rafii, M. S. (2025). “Being brave, being seen, and having your voice heard”: Perspectives of self‐advocates and families toward accessible and impactful research of Alzheimer's disease in down syndrome. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70999
Vancouver
Walter S, Ptomey L, Head E, Cohen A, Briones JM, Shaw H, et al. “Being brave, being seen, and having your voice heard”: Perspectives of self‐advocates and families toward accessible and impactful research of Alzheimer's disease in down syndrome. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70999
BibTeX
@article{Walter2025,
author = {Walter, Sarah and Ptomey, Lauren and Head, Elizabeth and Cohen, Ann and Briones, Joseph Mike and Shaw, Henry and Carter, Brandon and Kishner, Jessica and Pestolesi, Willie and Sciullo, Anthony and Olmstead, Katy Kolb and Carter, Aurelia and Kishner, Sara and Tucker, Amy Kolb and Pestolesi, Lissa and Briones, Maria and Sciullo, Dana and Sciullo, Kay and Shaw, Pam and Chen, Perry and Rafii, Michael S},
title = {“Being brave, being seen, and having your voice heard”: Perspectives of self‐advocates and families toward accessible and impactful research of Alzheimer's disease in down syndrome},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70999}
}
EUVIMED